![](https://axxam.com/wp-content/uploads/2024/05/Speaker-photo-in-circle-for-website_Gene.png)
Dr. Gene E. Ananiev serves as the Senior Program Manager within Promega Corporation’s Tailored R&D Solutions (TRS) team. In this role, he specializes in compound profiling and high-throughput screening (HTS), overseeing early-stage drug development projects for Promega clients. Dr. Ananiev brings a robust background in academic research to his position at Promega. Before his current role, he was the Director of an academic high-throughput screening center at the University of Wisconsin-Madison. His laboratory there was instrumental in designing and executing HTS campaigns aimed at identifying novel drug targets across various therapeutic areas, including neurodevelopmental disorders and infectious diseases. This extensive experience in HTS and drug target validation enhances his expertise in managing complex drug development projects, ensuring innovative solutions for Promega’s clients.